The Patient Voice Initiative invites patient groups and communities to join us for this three-part webinar series on patient-based evidence. In this webinar, we’ll focus on answering your questions about patient preference studies.

Including:

• Data that makes a difference and what patient-based evidence can add (Jo Watson, PBAC Deputy Chair)
• What is patient preference research and what can it do? (Dr Simon Fifer, CaPPRe and PVI)
• How and why Myeloma Australia uses patient preference research (Steve Roach, CEO, Myeloma Australia & Nella Combe, Nurse, Myeloma Australia)
• Time for your questions

This webinar is provided for free, thanks to the following sponsorship of the Patient Voice Initiative:

Gold Sponsors: Bristol-Myers Squibb; Lilly; Sanofi

Silver Sponsors: Astra Zeneca; Biogen; Janssen; MSD; Pfizer; Medicines Australia; Shire/Takeda

Ongoing inkind support: CaPPRe; Rare Cancers Australia

And the generosity of all speakers who have given their time for free.